Breaking News
May 25, 2018 - New guidelines may help pathologists to more accurately classify and diagnose invasive melanoma
May 25, 2018 - Immune cells promote lung cancer metastases by forming clots in tumors, study finds
May 25, 2018 - Can Excess Weight in Toddlers Cause Brain Drain?
May 25, 2018 - Studying insight
May 25, 2018 - Researchers reveal potent new mechanism of action for treatment of IBD
May 25, 2018 - Study shows lack of follow-up care for patients with concussion
May 25, 2018 - Study establishes the importance of haploid cells
May 25, 2018 - Coveted BMJ award bestowed on The Clatterbridge Cancer Center
May 25, 2018 - AACN outlines evidence-based protocols and clinical strategies to manage alarms
May 25, 2018 - Origami inspires researchers to develop new solution for tissue regeneration
May 25, 2018 - Melorheostosis – Genetics Home Reference
May 25, 2018 - Non-addictive pain medication changing therapy for substance use disorders
May 25, 2018 - Delayed lactate measurements in sepsis patients increase risk of in-hospital death
May 25, 2018 - Researchers identify novel epigenetic mutations as cause of neurodevelopmental, congenital disorders
May 25, 2018 - UD researchers examine connection between DNA replication in HPV and cancer
May 25, 2018 - Researchers identify neurons that play key role in aggressive behavior
May 25, 2018 - Researchers discover unexpected chemosensor pathway for predator odor-evoked innate fear behaviors
May 25, 2018 - Nearly one in three people know someone addicted to opioids
May 25, 2018 - Research suggests link between faulty gene, alcohol, and heart failure
May 25, 2018 - New findings could help fine-tune treatment for cancer patients
May 25, 2018 - New cancer treatment approach targets specific sugar receptors
May 25, 2018 - Skin responsible for uptake of cancer-causing compounds during barbecuing than lungs
May 25, 2018 - Early-onset cannabis use linked to further drug abuse problems
May 25, 2018 - Covered California takes aim at hospital C-section rates
May 25, 2018 - FDA Approves Palynziq (pegvaliase-pqpz) for the Treatment of Adults with Phenylketonuria
May 25, 2018 - Arthritis Glossary
May 25, 2018 - Study links breast cancer to the body’s internal clock
May 25, 2018 - Strenuous exercise in teenage years may protect against height loss later in life
May 25, 2018 - FDA approves novel enzyme therapy for adults with rare and serious genetic disease
May 25, 2018 - New research project aims at developing effective interventions for kids with DLD
May 25, 2018 - Middlemen who save $$ on medicines — but maybe not for you
May 25, 2018 - Study sheds new light on sharp rise in fatal drug overdoses in recent years
May 25, 2018 - Students propose revision of listeriosis guidelines for safer pregnancy
May 25, 2018 - TNFi Exposure In Utero Does Not Up Serious Infection Risk
May 25, 2018 - Organization of cells in the inner ear enables the sense and sensitivity of hearing
May 25, 2018 - Yoga May Be Right Move Against Urinary Incontinence
May 25, 2018 - Drinking recommended amount of milk could protect obese children against metabolic syndrome
May 25, 2018 - New cytokine network can repair tissue damage in the intestine, study finds
May 25, 2018 - Lyme disease researcher dispels misconceptions about ticks and provides prevention tips
May 25, 2018 - Penn researchers find link between social media usage and underage drinking
May 25, 2018 - Unique nanotechnology method to simplify skin disease diagnosis
May 25, 2018 - Study reveals new protective mechanism for tumor cells in breast cancer
May 25, 2018 - FRAME Alternatives Laboratory chosen for major European liver research collaboration
May 25, 2018 - Study shows yogurt may dampen chronic inflammation linked to multiple diseases
May 25, 2018 - Invasive cancers that are born to be bad show detectable differences from harmless tumors
May 25, 2018 - Study identifies new mechanism involved in development of Lou Gehrig’s disease
May 25, 2018 - UAB professor receives award for malaria prevention study in pregnant women in Cameroon
May 25, 2018 - Study provides blueprint of how fruit flies can be used to screen potentially pathogenic human genes
May 25, 2018 - New drug-delivering nanoparticle could offer better way to treat brain tumors
May 25, 2018 - Kessler Foundation scientists compare two tests for assessing learning in individuals with MS
May 25, 2018 - Stroke Symptoms and Diagnosis (Beyond the Basics)
May 25, 2018 - Protein goes against the family to prevent cancer
May 25, 2018 - Drugmakers blamed for blocking generics have milked prices and cost U.S. billions
May 25, 2018 - Speakers announced for National Medicines Symposium 2018
May 25, 2018 - GSK Receives FDA Approval of Arnuity Ellipta for Asthma in Children From 5 Years of Age
May 25, 2018 - Pfizer settles kickback case related to copay assistance for $24m
May 25, 2018 - Nuclear pore functions are essential for T cell survival
May 25, 2018 - Study defines molecular basis to explain connection between mother’s nutrition and infant growth
May 24, 2018 - IHI hosts representatives to develop a national action plan for patient safety
May 24, 2018 - Zika detection breakthrough by University of Queensland
May 24, 2018 - FDA Alert: 95% Ethyl Alcohol Product by Ethanol Extraction: Recall
May 24, 2018 - New method allows scientists to study how HIV persists
May 24, 2018 - Study reveals rate of vertebral and non-vertebral fractures in children with leukemia
May 24, 2018 - Whey protein supplementation and physical activity aid women in improving body composition
May 24, 2018 - Seniors’ air pollution exposure linked to hospitalization for ARDS
May 24, 2018 - Home-based telehealth therapy program effective for stroke rehabilitation, shows study
May 24, 2018 - Addressing Parents’ HPV Vaccine Hesitancy Ups Vaccination Rates
May 24, 2018 - Opioid addiction treatment drug helps suppress HIV in former prisoners
May 24, 2018 - FDA warns against using teething remedies for babies
May 24, 2018 - Healthy lifestyle counseling program linked to reduced risk of developing cancers
May 24, 2018 - CU research sheds light on liver disease caused by intravenous nutrition
May 24, 2018 - Skin cream containing rapamycin reduces TSC-related facial tumors
May 24, 2018 - Suicide rates twice as high among black children finds new study
May 24, 2018 - Researchers find new method to treat severe asthma
May 24, 2018 - Scientists report new strategy for fighting bacteria
May 24, 2018 - South Asians living in the United States more likely to die of heart disease and stroke
May 24, 2018 - Health Tip: Why Get a Biopsy
May 24, 2018 - Metabolic Syndrome Prevalence by Race/Ethnicity and Sex in the United States, National Health and Nutrition Examination Survey, 1988–2012
May 24, 2018 - Motivation to move may start with being mindful
May 24, 2018 - Advanced genetics study of TB bacteria uncovers virulent ‘Beijing lineage’ strain among young adults
ESRD Tied to ‘Exceptionally High’ Mortality Rates After LVAD Placement

ESRD Tied to ‘Exceptionally High’ Mortality Rates After LVAD Placement

image_pdfDownload PDFimage_print

Action Points

  • Patients with end-stage renal disease (ESRD) have an especially poor prognosis if they decide to get a left ventricular assist device (LVAD) for their advanced heart failure.
  • The study suggests that ESRD patients should ideally be informed about the very poor prognosis of most patients with ESRD who receive an LVAD.

Patients with end-stage renal disease (ESRD) have an especially poor prognosis if they decide to get a left ventricular assist device (LVAD) for their advanced heart failure, a small study suggested.

By a median of 762 days since LVAD placement — whether as bridge to heart transplant or destination therapy — 81.9% and 36.4% of ESRD and non-ESRD patients had died, respectively. During the index hospitalization, the odds of death in the two patient groups were 51.6% and 4%, according to Nisha Bansal, MD, MAS, of the University of Washington’s Kidney Research Institute in Seattle, and colleagues.

Even after accounting for factors like demographics and comorbidity, ESRD patients had a markedly higher risk of mortality (adjusted HR 36.3, 95% CI 15.6 to 84.5), with the survival gap widest between groups in the first 60 days (when 72.4% and 6.3% had died), the study published online in JAMA Internal Medicine showed.

“Patients with ESRD at the time of LVAD placement had an extremely poor prognosis, with most surviving for less than 3 weeks,” Bansal and colleagues concluded. “The median survival of 16 days after LVAD placement and high in-hospital mortality for patients with ESRD in this study suggests that these procedures are either being offered at a time when patients are actively dying or that they actually precipitate this process.”

Subjects in the study were Medicare beneficiaries with ESRD (those included in the U.S. Renal Data System registry for having received maintenance dialysis or a kidney transplant; n=155) compared with a 5% sample of peers without the condition (n=261).

Of the entire ESRD group, just 2.9% went on to have a heart transplant and were alive 1 year after LVAD placement.

In an accompanying invited commentary, Sunu Thomas, MD, MSc, of Massachusetts General Hospital in Boston, and colleagues, wrote: “There continues to be a variable practice in mechanical circulatory support utilization among marginal LVAD candidates with end-stage heart failure. We commend the authors for providing further corroborative data in support of current guidelines discouraging LVAD therapy in patients with ESRD.”

Notably, however, according to the commentary, it appeared that more and more patients with ESRD were getting LVADs over time: 0.32 per 10,000 person-years in the 2003-2006 period versus 0.45 per 10,000 in 2010-2013. “The seemingly indiscriminate use of implantable LVADs” may be due to the researchers’ reliance on ICD-9 coding to identify the study cohort — which may have thrown temporary and permanent circulatory support device use into the same mix, Thomas et al wrote.

“The current analysis warrants further elaboration to explain the exceptionally high mortality rate and the appropriateness of LVAD therapy in a recognized marginal mechanical circulatory support candidate population. Paramount among our concerns is the database from which the analysis is derived.”

The commentary also cited the study’s lack of details such as cause of death and concomitant use of acute circulatory support.

Bansal and colleagues acknowledged that their retrospective study was without granular data. In addition, they were not able to perform any subgroup analyses within the ESRD cohort due to the small sample size.

Baseline imbalances between groups were quite common, too: the ESRD group was slightly younger and counted fewer men, and had more black patients with a greater burden of comorbidity as well.

“A strength of our analysis is that we describe outcomes after LVAD placement among nationally representative cohorts,” the team wrote. “Unlike prior studies of outcomes among LVAD recipients with kidney failure, which we suspect have included mainly patients receiving acute dialysis, we studied Medicare beneficiaries with ESRD. Our results may help to inform treatment decisions in patients with ESRD and heart failure who are contemplating LVAD placement. These patients should ideally be informed about the very poor prognosis of most patients with ESRD who receive an LVAD.”

Bansal and colleagues reported no conflicts of interest.

Thomas and co-authors disclosed no conflicts of interest.

  • Reviewed by
    Robert Jasmer, MD Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner

1969-12-31T19:00:00-0500

last updated

Tagged with:

About author

Related Articles